1994
DOI: 10.1046/j.1471-4159.1994.62051906.x
|View full text |Cite
|
Sign up to set email alerts
|

Resistance of Golden Hamster to l‐Methyl‐4‐Phenyl‐1,2,3,6 Tetrahydropyridine: Relationship with Low Levels of Regional Monoamine Oxidase B

Abstract: Effects of acute and chronic administration of 1 ‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) were investigated for dopamine (DA) and its metabolites, 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid, in nucleus caudatus putamen (NCP), limbic system, and substantia nigra (SN) of golden hamster and BALB/c and C57/BL mice to obtain a clue for the variance of MPTP toxicity between the strains and species. Regional differences in the levels of monoamine oxidase (MAO) and the in vitro e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 43 publications
(12 citation statements)
references
References 34 publications
0
12
0
Order By: Relevance
“…In the brain MPTP is converted to its biologically active metabolite 1-methyl-4-phenylpyridinium (MPP+) by the action of MAO-B which is toxic to neurons (Chiba et al, 1984). Animals with low levels of MAO-B in the brain are resistant to this neurotoxin (Mitra et al, 1994).…”
Section: Short Communicationmentioning
confidence: 99%
“…In the brain MPTP is converted to its biologically active metabolite 1-methyl-4-phenylpyridinium (MPP+) by the action of MAO-B which is toxic to neurons (Chiba et al, 1984). Animals with low levels of MAO-B in the brain are resistant to this neurotoxin (Mitra et al, 1994).…”
Section: Short Communicationmentioning
confidence: 99%
“…It also caused parkinsonism in sub-human primates [4,5], cats [6], dogs [7], sheep [8] and mice [9,10]. Several species of mammals (such as rats and golden hamsters) have been shown to be resistant to the neurotoxin, which has been attributed to the inability of these animals to enzymatically convert MPTP into its active metabolite, 1-methyl-4-phenyl pyridinium ion (MPP + ) by the enzyme monoamine oxidase in the brain [11,12]. In consistent with this, MPP + has been shown to cause dopaminergic neurotoxicity when administered intracranially either in the substantia nigra pars compacta (SNpc), striatum or median forebrain bundle [13][14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…), 16 h apart, a dose regime which has been shown to cause 50% or more striatal DA depletion in this strain of mice [15]. Balb/c strain of mice is shown to be resistant to MPTP administration by some [16,17].…”
Section: Chemicalsmentioning
confidence: 86%
“…The former two studies [16,17] have reported single dose effect on Balb/c mice, while others have resorted to singular or multiple higher doses. A comparative study with eight strains of mice receiving singular 20 mg/kg dose [18] or three doses (30 mg/kg, daily) [19], or two doses (30 mg/ kg) separated by several hours (16 h apart) [15] provided convincing evidences for the susceptibility of Balb/c mice to MPTP. Interestingly, we have reported higher neurotoxicity in Balb/c mice compared to C57/BL6 mice in terms of striatal dopamine depletion following 10 mg/kg for 10 days, and analyzed after 30 days [15].…”
Section: Chemicalsmentioning
confidence: 97%
See 1 more Smart Citation